301 related articles for article (PubMed ID: 24508382)
1. Diagnostic utility of molecular investigation in extraskeletal myxoid chondrosarcoma.
Benini S; Cocchi S; Gamberi G; Magagnoli G; Vogel D; Ghinelli C; Righi A; Picci P; Alberghini M; Gambarotti M
J Mol Diagn; 2014 May; 16(3):314-23. PubMed ID: 24508382
[TBL] [Abstract][Full Text] [Related]
2. Extraskeletal myxoid chondrosarcoma with non-EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology.
Agaram NP; Zhang L; Sung YS; Singer S; Antonescu CR
Hum Pathol; 2014 May; 45(5):1084-91. PubMed ID: 24746215
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence in situ hybridization analysis of extraskeletal myxoid chondrosarcomas using EWSR1 and NR4A3 probes.
Noguchi H; Mitsuhashi T; Seki K; Tochigi N; Tsuji M; Shimoda T; Hasegawa T
Hum Pathol; 2010 Mar; 41(3):336-42. PubMed ID: 19775727
[TBL] [Abstract][Full Text] [Related]
4. Extraskeletal myxoid chondrosarcoma with a t(9;16)(q22;p11.2) resulting in a NR4A3-FUS fusion.
Broehm CJ; Wu J; Gullapalli RR; Bocklage T
Cancer Genet; 2014 Jun; 207(6):276-80. PubMed ID: 25130955
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of extraskeletal myxoid chondrosarcoma in the thigh using EWSR1-NR4A3 gene fusion: a case report.
Kobayashi H; Kikuta K; Sekita T; Susa M; Nishimoto K; Sasaki A; Kameyama K; Sugita S; Hasegawa T; Nakamura M; Matsumoto M; Morioka H
J Med Case Rep; 2016 Nov; 10(1):321. PubMed ID: 27832806
[TBL] [Abstract][Full Text] [Related]
6. Activity of sunitinib in extraskeletal myxoid chondrosarcoma.
Stacchiotti S; Pantaleo MA; Astolfi A; Dagrada GP; Negri T; Dei Tos AP; Indio V; Morosi C; Gronchi A; Colombo C; Conca E; Toffolatti L; Tazzari M; Crippa F; Maestro R; Pilotti S; Casali PG
Eur J Cancer; 2014 Jun; 50(9):1657-64. PubMed ID: 24703573
[TBL] [Abstract][Full Text] [Related]
7. NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas.
Brenca M; Stacchiotti S; Fassetta K; Sbaraglia M; Janjusevic M; Racanelli D; Polano M; Rossi S; Brich S; Dagrada GP; Collini P; Colombo C; Gronchi A; Astolfi A; Indio V; Pantaleo MA; Picci P; Casali PG; Dei Tos AP; Pilotti S; Maestro R
J Pathol; 2019 Sep; 249(1):90-101. PubMed ID: 31020999
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of NOR1 and SIX3 proteins in extraskeletal myxoid chondrosarcomas without detectable NR4A3 fusion genes.
Hisaoka M; Okamoto S; Yokoyama K; Hashimoto H
Cancer Genet Cytogenet; 2004 Jul; 152(2):101-7. PubMed ID: 15262426
[TBL] [Abstract][Full Text] [Related]
9. Extraskeletal Myxoid Chondrosarcomas: The Uncommon Clinicopathologic Manifestations and Significance of TAF15::NR4A3 Fusion.
Huang SC; Lee JC; Hsu YC; Tsai JW; Kao YC; Hsieh TH; Chang YM; Chang KC; Wu PS; Chen PC; Chen CH; Chang CD; Lee PH; Tai HC; Liu TT; Wen MC; Li WS; Yu SC; Wang JC; Huang HY
Mod Pathol; 2023 Jul; 36(7):100161. PubMed ID: 36948401
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma.
Wang WL; Mayordomo E; Czerniak BA; Abruzzo LV; Dal Cin P; Araujo DM; Lev DC; López-Terrada D; Lazar AJ
Mod Pathol; 2008 Nov; 21(11):1303-10. PubMed ID: 18587326
[TBL] [Abstract][Full Text] [Related]
11. HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma.
Urbini M; Astolfi A; Pantaleo MA; Serravalle S; Dei Tos AP; Picci P; Indio V; Sbaraglia M; Benini S; Righi A; Gambarotti M; Gronchi A; Colombo C; Dagrada GP; Pilotti S; Maestro R; Polano M; Saponara M; Tarantino G; Pession A; Biasco G; Casali PG; Stacchiotti S
Genes Chromosomes Cancer; 2017 Jul; 56(7):582-586. PubMed ID: 28383167
[TBL] [Abstract][Full Text] [Related]
12. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms.
Downs-Kelly E; Goldblum JR; Patel RM; Weiss SW; Folpe AL; Mertens F; Hartke M; Tubbs RR; Skacel M
Am J Surg Pathol; 2008 Jan; 32(1):8-13. PubMed ID: 18162764
[TBL] [Abstract][Full Text] [Related]
13. A novel sarcoma with dual differentiation: clinicopathologic and molecular characterization of a combined synovial sarcoma and extraskeletal myxoid chondrosarcoma.
Vergara-Lluri ME; Stohr BA; Puligandla B; Brenholz P; Horvai AE
Am J Surg Pathol; 2012 Jul; 36(7):1093-8. PubMed ID: 22743288
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma.
Panagopoulos I; Mertens F; Isaksson M; Domanski HA; Brosjö O; Heim S; Bjerkehagen B; Sciot R; Dal Cin P; Fletcher JA; Fletcher CD; Mandahl N
Genes Chromosomes Cancer; 2002 Dec; 35(4):340-52. PubMed ID: 12378528
[TBL] [Abstract][Full Text] [Related]
15. SMARCA2-NR4A3 is a novel fusion gene of extraskeletal myxoid chondrosarcoma identified by RNA next-generation sequencing.
Wei S; Pei J; von Mehren M; Abraham JA; Patchefsky AS; Cooper HS
Genes Chromosomes Cancer; 2021 Oct; 60(10):709-712. PubMed ID: 34124809
[TBL] [Abstract][Full Text] [Related]
16. The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene.
Filion C; Motoi T; Olshen AB; Laé M; Emnett RJ; Gutmann DH; Perry A; Ladanyi M; Labelle Y
J Pathol; 2009 Jan; 217(1):83-93. PubMed ID: 18855877
[TBL] [Abstract][Full Text] [Related]
17. Osseous myxochondroid sarcoma: a detailed study of 5 cases of extraskeletal myxoid chondrosarcoma of the bone.
Demicco EG; Wang WL; Madewell JE; Huang D; Bui MM; Bridge JA; Meis JM
Am J Surg Pathol; 2013 May; 37(5):752-62. PubMed ID: 23588370
[TBL] [Abstract][Full Text] [Related]
18. Extraskeletal myxoid chondrosarcoma: A study of 17 cases focusing on the diagnostic utility of INSM1 expression and presenting rare morphological variants associated with non-EWSR1::NR4A3 fusions.
Lenz J; Klubíčková N; Ptáková N; Hájková V; Grossmann P; Šteiner P; Kinkor Z; Švajdler M; Michal M; Konečná P; Macháčová D; Hurník P; Tichý M; Tichý F; Kyllar M; Fiala L; Kavka M; Michal M
Hum Pathol; 2023 Apr; 134():19-29. PubMed ID: 36563884
[TBL] [Abstract][Full Text] [Related]
19. The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities.
Noujaim J; Jones RL; Swansbury J; Gonzalez D; Benson C; Judson I; Fisher C; Thway K
Br J Cancer; 2017 Feb; 116(5):669-678. PubMed ID: 28141799
[TBL] [Abstract][Full Text] [Related]
20. Extraskeletal myxoid chondrosarcoma: combining cytopathology with molecular testing to achieve diagnostic accuracy.
Wakely PE
J Am Soc Cytopathol; 2021; 10(3):293-299. PubMed ID: 32828707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
